STEVANATO GROUP SPA (STVN) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:STVN - IT0005452658 - Common Stock
STVN Key Statistics, Chart & Performance
The current stock price of STVN is 17.27 USD. In the past month the price decreased by -17.13%. In the past year, price decreased by -19.82%.
STVN Technical Analysis
STVN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to STVN. STVN has an excellent profitability rating, but there are some minor concerns on its financial health.
STVN Financial Highlights
Over the last trailing twelve months STVN reported a non-GAAP Earnings per Share(EPS) of 0.63. The EPS increased by 14.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.72% | ||
| ROA | 5.71% | ||
| ROE | 9.6% | ||
| Debt/Equity | 0.24 |
STVN Forecast & Estimates
17 analysts have analysed STVN and the average price target is 29.57 USD. This implies a price increase of 71.24% is expected in the next year compared to the current price of 17.27.
For the next year, analysts expect an EPS growth of 11.64% and a revenue growth 7.07% for STVN
STVN Ownership
About STVN
Company Profile
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 5,521 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Company Info
STEVANATO GROUP SPA
Piombino Dese (Pd) Via Molinella, 17
Piombino Dese PADOVA IT
CEO: Franco Moro
Employees: 5521
Phone: 390499318173
STEVANATO GROUP SPA / STVN FAQ
What does STEVANATO GROUP SPA do?
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 5,521 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
What is the stock price of STEVANATO GROUP SPA today?
The current stock price of STVN is 17.27 USD. The price decreased by -9.86% in the last trading session.
Does STEVANATO GROUP SPA pay dividends?
STEVANATO GROUP SPA (STVN) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.06.
How is the ChartMill rating for STEVANATO GROUP SPA?
STVN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the market expecting STVN stock to perform?
17 analysts have analysed STVN and the average price target is 29.57 USD. This implies a price increase of 71.24% is expected in the next year compared to the current price of 17.27.
Is STEVANATO GROUP SPA (STVN) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on STVN.
What is the Short Interest ratio of STEVANATO GROUP SPA (STVN) stock?
The outstanding short interest for STEVANATO GROUP SPA (STVN) is 4.92% of its float.